Arnold Financial Planning’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$429K Hold
2,718
– – 0.29% 28
2026
Q2
$430K Buy
+2,718
New +$367K 0.32% 26

Other funds holding XBI

Arnold Financial Planning's XBI Position: Q3 2026 in Review

Arnold Financial Planning held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q3 2026 at 2,718 shares worth $429K. The position accounts for 0.29% of the portfolio, ranked #28.

Arnold Financial Planning first reported a position in XBI in Q2 2026 and has held it in 2 quarters since. The position peaked at $430K in Q2 2026. 961 funds tracked by Wall St. Rank hold XBI as of Q3 2026.

  • Arnold Financial Planning held 2,718 shares of State Street SPDR S&P Biotech ETF worth $429K as of Q3 2026.
  • Arnold Financial Planning left its State Street SPDR S&P Biotech ETF share count unchanged in Q3 2026.
  • State Street SPDR S&P Biotech ETF made up 0.29% of Arnold Financial Planning's portfolio in Q3 2026, its #28 holding.
  • Arnold Financial Planning first reported a position in State Street SPDR S&P Biotech ETF in Q2 2026 and has held it in 2 quarters since.
  • Arnold Financial Planning's State Street SPDR S&P Biotech ETF position peaked at $430K in Q2 2026.
  • 961 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.

Based on Arnold Financial Planning's 13F filing for Q3 2026, filed 20 Oct 2026.